IHC - Follicle Stimulating Hormone -Test, Price, Normal Range | Sprint Diagnostics Hyderabad

No, this test uses a tissue sample and doesn't require fasting.

The tissue sample is obtained via a biopsy, a procedure in which a small amount of tissue is removed for testing.

Each marker in the panel - S100, HMB45, and Melan A - is a protein commonly found in melanoma cells. Their presence in the tissue sample can indicate the presence of melanoma.

Typically, results are available within 7 to 10 days.

No specific preparation is required. Follow the instructions given by your healthcare provider regarding the biopsy procedure.

This test is usually performed when there are suspicions of melanoma, often following a physical examination of the skin.

The test measures the presence of the specific proteins S100, HMB45, and Melan A in the tissue sample, which could indicate melanoma.

This test is generally conducted once for diagnosis but may be repeated in case of suspicion of recurrence or progression.

In a healthy tissue sample, these markers would typically not be present. Their presence may suggest melanoma.

The main precautions relate to the biopsy procedure. Discuss with your healthcare provider about any risks and potential complications.

These markers are primarily affected by the presence of melanoma. Factors that increase the risk of melanoma, like excessive sun exposure and genetic predisposition, can influence these markers.

If the test results are abnormal, you should consult a dermatologist or an oncologist who specializes in skin cancers.

Yes, other tests like genetic testing or additional imaging scans may be conducted based on your healthcare provider's advice.

The IHC test is highly accurate, but results should be interpreted in conjunction with other diagnostic information and clinical symptoms.

Understanding the IHC diagnostic panel for melanoma is critical in managing this skin cancer. These tests provide invaluable information that helps in formulating the right treatment strategy. It is essential to have an open conversation with your healthcare provider about the implications of your results and the next steps for your care. It's equally important to remember that early detection and prompt treatment often lead to the best outcomes in melanoma, making these tests a crucial tool in ensuring your health.